Literature DB >> 14651780

Activity of hybrid type I interferons in cells lacking Tyk2: a common region of IFN-alpha 8 induces a response, but IFN-alpha2/8 hybrids can behave like IFN-beta.

Dimitris Platis1, Graham R Foster.   

Abstract

Type I interferons (IFNs) are a family of pleiotropic cytokines with antiviral, antiproliferative, and immunomodulatory properties. The type I IFN family consists of 12 IFN-alpha subtypes, IFN-beta, and IFN-omega. Cells lacking the receptor-associated protein kinase Tyk2 (U1A) are responsive only to IFN-beta and partially to IFN-alpha8. We constructed a series of IFN-alpha2/alpha8 hybrids and mutants and identified the region within IFN-alpha8 responsible for its activity in Tyk2-deficient cells. The same domain mediates the interactions between IFN and IFN-alpha receptor (IFNAR) in Tyk2-complemented and Tyk2-deficient cells (U1A). The presence or absence of Tyk2 altered the inhibitory effects of anti-IFNAR antibodies, suggesting that the IFN-alpha binding domain on IFNAR is altered by the presence of Tyk2. The activity of IFN-beta was not significantly affected by the deletion of Tyk2, and, surprisingly, one of our IFN-alpha2/alpha8 hybrids (IFN-alpha288) behaved like IFN-beta in a number of assays that distinguish IFN-alphas from IFN-beta. This suggests that this hybrid mimics the interactions of IFN-beta with the receptor and also suggests the existence of a distinct binding site(s) on IFNAR for IFN-beta and some hybrid IFN-alphas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14651780     DOI: 10.1089/107999003322558791

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  3 in total

1.  Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection.

Authors:  Luna Alammar; Lucio Gama; Janice E Clements
Journal:  J Immunol       Date:  2011-03-02       Impact factor: 5.422

Review 2.  Type I interferon in organ-targeted autoimmune and inflammatory diseases.

Authors:  Mary K Crow
Journal:  Arthritis Res Ther       Date:  2010-08-25       Impact factor: 5.156

3.  An orally available, small-molecule interferon inhibits viral replication.

Authors:  Hideyuki Konishi; Koichi Okamoto; Yusuke Ohmori; Hitoshi Yoshino; Hiroshi Ohmori; Motooki Ashihara; Yuichi Hirata; Atsunori Ohta; Hiroshi Sakamoto; Natsuko Hada; Asao Katsume; Michinori Kohara; Kazumi Morikawa; Takuo Tsukuda; Nobuo Shimma; Graham R Foster; William Alazawi; Yuko Aoki; Mikio Arisawa; Masayuki Sudoh
Journal:  Sci Rep       Date:  2012-02-10       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.